Skip to main content


We're creating a new version of this page. See preview

  • Commentary
  • Open Access

Blood flow, not hypoxia, determines intramucosal PCO2

Critical Care20059:149

  • Published:


Monitoring tissue hypoxia in critically ill patients is a challenging task. Tissue PCO2 has long been proposed as a marker of tissue hypoxia, although there is considerable controversy on whether the rise in CO2 with hypoxia is caused by anaerobic metabolism and excess CO2 production or by the accumulation of aerobically produced CO2 in the setting of blood flow stagnation. The prevention of increases in intestinal PCO2 in aggressively resuscitated septic animals supports the notion that tissue CO2 accumulation is a function of decreases in blood flow, not of tissue hypoxia.


  • Tissue Hypoxia
  • Ischemic Hypoxia
  • Septic Animal
  • Poor Patient Outcome
  • Intestinal Blood Flow

Hypotension is strongly associated with poor patient outcome, and reversing this condition clearly should be a primary therapeutic goal when treating patients in the early stages of shock. Potent inotropic and vasoconstrictor agents are de rigueur in the treatment of shock. The therapeutic goal is to maintain the mean arterial pressure at levels above 60 mmHg, a value thought to be the minimal pressure head required for coronary and renal perfusion [1]. Our predicament is how best to determine the mean arterial pressure level that will result in optimal tissue perfusion in a given patient. In other words, is a mean arterial pressure of 60 mmHg sufficient to assure adequate perfusion to all organs? In some patients this accepted minimal mean arterial pressure may not suffice to insure adequate tissue perfusion. Should we aim for higher, or perhaps even lower, mean arterial pressure values? Catecholamines, while extremely useful in treating decreases in cardiac output, may produce an unwelcome increase in myocardial O2 consumption in cardiogenic shock, or may impede blood flow to oxygen-starved tissues in hypovolemic shock [2]. In septic shock, the balance between the positive and the negative effects of vasopressor and inotropic agents are even more difficult to discern [3].

A reliable and practical method to detect the onset of tissue hypoxia in critically ill patients would be an invaluable tool in guiding the timing and aggressiveness of resuscitation efforts. Finding such a tool has bedeviled clinical investigators for many years. Given our present level of technology, our options in determining the adequacy of tissue oxygenation in the clinical setting remain limited. Direct measures of tissue oxygen concentration are not sufficient to characterize the complex interaction between cellular energy requirements and oxygen supply. More complex technology, such as magnetic resonance spectroscopy and near-infrared spectroscopy are either insensitive or impractical in the clinical setting.

A great deal of thinking has been devoted in the past to the relationship of systemic measures of O2 delivery to O2 consumption [4]. Enthusiastic acceptance of the 'supranormal' O2 delivery concept, produced by the infusion of fluid volume, inotropic agents and blood products [5], has been tempered by studies finding no efficacy [6], or even increased mortality [7], with this approach. Other clinical studies, however, have shown improved survival in individuals when treated immediately upon their arrival at the emergency department with a protocol designed to increase O2 delivery [8]. It appears that early efforts at resuscitation are critical to survival, whereas delays in restoring adequate O2 delivery may result in an ischemia-reperfusion-type phenomenon and in greater mortality [9].

Measuring tissue PCO2 with a gastric tonometer [10] or a sublingual tonometer [11, 12] has been proposed as a physiologically sound method of detecting decreases in organ perfusion. Although numerous clinical and experimental studies show a strong correlation between increases in tissue PCO2 and poor patient outcome, gastric tonometry or sublingual tonometry have encountered variable clinical acceptance. Technical difficulties certainly have dampened the initial enthusiasm for PCO2 tonometry, but a more challenging obstacle to the widespread use of this technology has been an inadequate understanding of the mechanism(s) that result in tissue CO2 accumulation. A crucial issue regarding the physiology of tissue CO2 accumulation is whether the rise in tissue PCO2 results from decreases in cellular O2 delivery (or metabolism by mitochondria) or from decreases in blood flow and the accumulation of 'aerobic' CO2 generated in the tricarboxylic acid cycle [13].

Dubin and colleagues [14] explored this issue in the past by subjecting experimental animals to decreases in O2 delivery produced by lowering flow (ischemic hypoxia) or by lowering arterial oxygen saturation (hypoxic hypoxia). There were increases in intestinal venous PCO2 with ischemic hypoxia but not with hypoxic hypoxia. Given that both preparations presumably experienced similar degrees of tissue hypoxia, this finding suggests that blood flow, not dysoxia, is the primary determinant of increases in tissue PCO2. This conclusion, moreover, was in consonance with the results obtained by Vallet and colleagues [15] in isolated dog skeletal muscle.

In the current issue of Critical Care, Dubin and colleagues [16] extend their findings by testing the hypothesis that increasing intestinal blood flow prevents a rise in tissue PCO2 in septic animals. They subjected two groups of sheep to lipopolysaccharide infusion. One group received intravenous fluids at a rate that maintained baseline intestinal blood flow. The other group was aggressively fluid resuscitated, resulting in increases of 50% in intestinal blood flow over basal conditions. An additional group of animals served as a normal control. The intramucosal-to-arterial PCO2 difference (ΔPCO2) rose in the first group, whereas volume expansion prevented increases in ΔPCO2 in the aggressively resuscitated group. Of interest, metabolic acidosis as evidenced by a widening of the anion gap was greater in the resuscitated group.

The avoidance of increases in tissue PCO2 in this model of resuscitated sepsis supports the notion that hypoperfusion, not tissue hypoxia, is the mechanism responsible for the accumulation of CO2 in tissues. This finding provides experimental validity to the concept developed in a mass transport model of tissue CO2 exchange [17], in which increases in tissue and venous blood CO2 concentration are shown to be markers of regional hypoperfusion and not of tissue hypoxia.

The mechanism responsible for the increased anion-gap acidosis due to unmeasured anions in the resuscitated animals cannot be ascertained from the measurements obtained in this study. It is conceivable that resuscitation with normal saline may have produced local tissue hypoxia, the result of O2 radical species production. Measurements of intestinal lactate production would have been helpful in answering this question by establishing the degree of anerobiasis in the resuscitated animals.

The study of Dubin and colleagues is another milepost in our understanding of the mechanisms that govern increases in tissue PCO2 during hypoxic and septic conditions. Since changes in tissue PCO2 are likely to be determined by alterations in blood flow, this may explain why gastric mucosal PCO2 improves with greater cardiac output but not with increases in O2-carrying capacity produced by blood transfusions [18].

I believe that now is the time to renew our interest in clinical measures of tissue PCO2, as we understand further the clinical importance of gastric and sublingual tonometry as markers of regional tissue perfusion.


Authors’ Affiliations

Pulmonary and Critical Care Medicine Division, Department of Medicine, The George Washington University Medical Center, Washington, USA


  1. Bersten AD, Holt AW: Vasoactive drugs and the importance of renal perfusion pressure. New Horiz 1995, 3: 650-661.PubMedGoogle Scholar
  2. Asfar P, De Backer D, Meier-Hellmann A, Radermacher P, Sakka SG: Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock. Crit Care 2004, 8: 170-179. 10.1186/cc2418PubMed CentralView ArticlePubMedGoogle Scholar
  3. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, et al.: Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004, 32: 1928-1948. 10.1097/01.CCM.0000139761.05492.D6View ArticlePubMedGoogle Scholar
  4. Vincent JL, De Backer D: Oxygen transport – the oxygen delivery controversy. Intensive Care Med 2004, 30: 1990-1996. 10.1007/s00134-004-2384-4View ArticlePubMedGoogle Scholar
  5. Kern JW, Shoemaker WC: Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med 2002, 30: 1686-1692. 10.1097/00003246-200208000-00002View ArticlePubMedGoogle Scholar
  6. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R: A trial of goal-oriented hemodynamic therapy in critically ill patients. S v O 2 Collaborative Group. N Engl J Med 1995, 333: 1025-1032. 10.1056/NEJM199510193331601View ArticlePubMedGoogle Scholar
  7. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994, 330: 1717-1722. 10.1056/NEJM199406163302404View ArticlePubMedGoogle Scholar
  8. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345: 1368-1377. 10.1056/NEJMoa010307View ArticlePubMedGoogle Scholar
  9. Balogh Z, McKinley BA, Cocanour CS, Kozar RA, Valdivia A, Sailors RM, Moore FA: Supranormal trauma resuscitation causes more cases of abdominal compartment syndrome. Arch Surg 2003, 138: 637-642. 10.1001/archsurg.138.6.637View ArticlePubMedGoogle Scholar
  10. Gutierrez G, Taylor D: Gastrointestinal tonometry: basic principles and recent advances in monitoring regional CO 2 metabolism. Semin Respir Crit Care Med 1999, 20: 17-27.View ArticleGoogle Scholar
  11. Toledo Maciel A, Creteur J, Vincent JL: Tissue capnometry: does the answer lie under the tongue? Intensive Care Med 2004, 30: 2157-2165. 10.1007/s00134-004-2416-0View ArticleGoogle Scholar
  12. Totapally BR, Fakioglu H, Torbati D, Wolfsdorf J: Esophageal capnometry during hemorrhagic shock and after resuscitation in rats. Crit Care 2003, 7: 79-84. 10.1186/cc1856PubMed CentralView ArticlePubMedGoogle Scholar
  13. Vallet B: Influence of flow on mucosal-to-arterial carbon dioxide difference. Crit Care 2002, 6: 463-464. 10.1186/cc1845PubMed CentralView ArticlePubMedGoogle Scholar
  14. Dubin A, Murias G, Estenssoro E, Canales H, Badie J, Pozo M, Sottile JP, Baran M, Palizas F, Laporte M: Intramucosal–arterial PCO 2 gap fails to reflect intestinal dysoxia in hypoxic hypoxia. Crit Care 2002, 6: 514-520. 10.1186/cc1813PubMed CentralView ArticlePubMedGoogle Scholar
  15. Vallet B, Teboul JL, Cain S, Curtis S: Venoarterial CO 2 difference during regional ischemic or hypoxic hypoxia. J Appl Physiol 2000, 89: 1317-1321.PubMedGoogle Scholar
  16. Dubin A, Murias G, Maskin B, Pozo MO, Sottile JP, Barán M, Edul VSK, Canales HS, Badie JC, Etcheverry G, Estenssoro E: Increased blood flow prevents intramucosal acidosis in sheep endotoxemia: a controlled study. Critical Care 2005, 9: R66-R73. 10.1186/cc3021PubMed CentralView ArticlePubMedGoogle Scholar
  17. Gutierrez G: Tissue CO 2 concentration is not a marker of dysoxia: a mathematical model of CO 2 exchange. Am J Respir Crit Care Med 2004, 169: 525-533. 10.1164/rccm.200305-702OCView ArticlePubMedGoogle Scholar
  18. Silverman HJ, Tuma P: Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red blood cell transfusions. Chest 1992, 102: 184-188.View ArticlePubMedGoogle Scholar


© BioMed Central Ltd 2005